2014.1-8 FDA approved drug

2014.1-8 FDA approved drug

No.	Drug Name	Active Ingredient	Date	What It’s Used For
23.	Orbactiv	oritavancin	8/6/2014	To treat adults with skin  infections 8 b, B/ M) w. u# ^  Press Release
22.	Jardiance	empagliflozin	8/1/2104	To improve gylcemic control  in adults with type 2 diabetes 1 S  c2 ~9 p& _! g' U2 U# }  Press Release
21.	Striverdi  Respimat	olodaterol	7/31/2014	To treat chronic obstructive  pulmonary disease   Press Release
20. 5 C" I& Q2 z6 k" S   2 X  i( p, h. f# l! f4 u	Zydelig	idelalisib	7/23/2014	To treat patients with trhee  types of blood cancers % T/ m  I) P. J8 L+ a1 L  Press Release
19.	Kerydin    ' K, J) F4 L( B3 @5 i5 `' U	tavaborole	7/7/2014	For the topical treatment of  onychomycosis of the toenails   (No Press Release)
18.	Beleodaq	belinostat	7/3/2014	To treat patients with  peripheral T-cell lymphoma (PTCL)   Press Release
17.	Sivextro (tablet)Sivextro  (injection)	tedizolid phosphate	6/20/2014	To treat adults with skin  infections   Press Release
16.	Jublia	efinaconazole	6/6/2014	Treat mild to moderate  onychomycosis (fungal infection)    No Press Release
15.	Dalvance	dalbavancin	5/23/2014	To treat adults with skin  infections 5 {- b: K' E! L8 r5 K: [  Press Release
14.	Entyvio    ' P# @9 o& F" q	vedolizumab	5/20/2014	To treat adult patients with  moderate to severe ulcerative colitis and adult patients with moderate to  severe Crohn‘s disease $ I: J! U4 W) Z; O  Press Release
13.	Zontivity    9 F6 p5 W3 \* u8 T	vorapaxar	5/8/2014	To reduce the risk of heart  attacks and stroke in high-risk patients   Press Release
12.	Zykadia	ceritinib	4/29/2014	To treat patients with a  certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC)   Press Release
11.	Sylvant	siltuximab	4/23/2014	To treat patients with multicentric  Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the  lymph nodes) : ?6 a( h4 {- ], R  Press Release
10.	Cyramza	ramucirumab	4/21/2014	To treat patients with  advanced stomach cancer or gastroesophageal junction adenocarcinoma 1 N7 ?$ `, ^2 H/ Q0 Z& X  Press Release
9.	Tanzeum	albiglutide	4/15/2014	To improve glycemic control,  along with diet and exercise, in adults with type 2 diabetes 5 U& t2 ?  Q/ K; F7 v- t+ N" M  Press Release
8.	Otezla	apremilast	3/21/2014	To treat adults with active  psoriatic arthritis (PsA)   Press Release
7.	Impavido	miltefosine	3/19/2014	To treat a tropical disease  called leishmaniasis , ^  g  d1 b" u, L. E  Press Release
6.	Neuraceq	florbetaben F 18 injection	3/19/2014	For Positron  EmissionTomography (PET) imaging of the brain
5.	Myalept	metreleptin for injection	2/24/2014	To treat the complications  of leptin deficiency   Press Release
4.	Northera	droxidopa	2/18/2014	To treat neurogenic  orthostatic hypotension (NOH) " R5 W1 k! t6 N  Press Release
3.	Vimizim	elosulfase alfa	2/14/2014	Treatment for Mucopolysaccharidosis Type IVA  (Morquio A syndrome) & K# [. l: _" `" `  Press Release
2.	Hetlioz	tasimelteon	1/31/2014	To treat non-24- hour sleep-wake disorder (“non-24”)  in totally blind individuals. Non-24 is a chronic circadian rhythm (body  clock) disorder in the blind that causes problems with the timing of sleep.Press Release
1.	Farxiga	dapaglifozin	1/8/2014	To improve glycemic control,  along with diet and exercise, in adults with type 2 diabetes   Press Release

/ C4 _  x5 _; P$ X9 v) m

# L$ w9 y" Z3 x3 o/ K4 u% x

感谢楼主分享，楼主好强大